FDAFDA · Food and drugs·Recall number D-0492-2017
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Published March 15, 2017 · Recall initiated: January 19, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide
- UPC
- 0303783545936
- Lot
- a) 3078937 and 3078938 (NDC 0378-3545-93), exp August 2019 b) 3078937 (NDC 0378-3545-01), exp August 2019 c) 3078936 (0378-3545-05), exp August 2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.